Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Valeo Pharma Inc VPHIF

Valeo Pharma Inc. is a Canadian pharmaceutical company. The Company acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler, Atectura Breezhaler and Allerject. The ophthalmology products include Xiidra and Simbrinza. Its specialty products include Redesca, Onstryv, M-Eslon, Yondelis and Ametop Gel 4%. The Company's wholly owned subsidiary is VPI Pharmaceuticals Inc.


GREY:VPHIF - Post by User

Post by oiljack14on Sep 14, 2020 12:14pm
205 Views
Post# 31553020

Another insider buy

Another insider buy
Filed 2020-09-14 09:19
 
Tx date 2020-09-10
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Warrants VPH.WT. A.(10SEP2022 Warrants)
15 - Acquisition or disposition under a prospectus

+12,500 vol
12,500  
Filed 2020-09-14 09:12
 
Tx date 2018-12-27
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Warrants VPH.WT. A.(10SEP2022 Warrants)
00 - Opening Balance-Initial SEDI Report
     
Filed 2020-09-14 09:12
 
Tx date 2020-09-10
$VPH
VALEO PHARMA INC.
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares Class A
15 - Acquisition or disposition under a prospectus
$30,000
+25,000 vol
$1.20 each 

<< Previous
Bullboard Posts
Next >>